Dr. Sridhar Nimmagadda

Radiology, Medicine, Pharmacology and Molecular Sciences and Oncology School of Medicine, Baltimore, USA.

Speaker 1


Sridhar Nimmagadda, Ph.D. is an Associate Professor of Radiology and Oncology, with joint appointments in Medicine, Clinical Pharmacology, and Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine (JHU SOM). He serves as the Scientific Director of the Johns Hopkins Center for Translational Molecular Imaging, a center dedicated to clinical translation of molecular imaging agents.

Dr. Nimmagadda received a Master of Science degree in Chemistry from the Indian Institute of Technology, Madras and a Ph.D. in Cancer Biology in 2005 from Wayne State University/Karmanos Cancer Institute. Dr. Nimmagadda’s current research is focused on the development of novel imaging agents for chemokine receptors and immune cell related targets (PD-L1), and the application of those agents to quantify drug-target engagement at the tumor. This work is supported by NIH, DOD and several private foundations. He has authored 60 publications that focus on targeted imaging agent development and applying imaging techniques to characterize tumor biology.

Research Interest:

  • Molecular imaging probes
  • chemokine receptors in cancer therapy and imaging
  • immune modulation therapies
  • non-invasive assessment of tumor response to therapy